Aehr Test Systems: Analyst Initiates Buy, But DeepValue Report Cautions on Execution

What happened

A Seeking Alpha analyst initiated Aehr Test Systems with a Buy rating and $144 price target, citing a $41 million hyperscale order as proof the Sonoma platform is moving from validation to production. However, the DeepValue master report maintains a WAIT rating, noting that Q2 FY26 revenue fell 44% YoY to $10.3M and net losses persist despite record bookings. The report warns the stock at $115 already discounts a steep ramp, with negative earnings and free cash flow offering no margin of safety. The key risk is that the $41M order, scheduled for FY27 shipments, may not convert due to cancellable purchase orders and customer concentration. The analyst's $1.0 incremental EPS and 144x P/E multiple contrast with the report's base case of $115, requiring shipment proof before underwriting such valuation.

Implication

Investors should remain cautious. The bullish thesis hinges on conversion of record bookings into revenue, but the DeepValue report highlights lumpy revenue, extreme customer concentration (42% from one customer), and uncertain backlog quality. While the analyst's $144 target is appealing, the base case valuation is $115 and bear case $85 if shipments slip. Only consider adding after FY27 results show sequential revenue acceleration and improving gross margins. The ATM equity usage and insider selling also raise governance concerns. The risk/reward is asymmetric to the downside at current levels.

Thesis delta

The new article reinforces the bullish AI burn-in narrative but does not change the DeepValue thesis, which remains skeptical until shipment cadence is proven. The delta is that the article's $144 target is higher than the report's bull case of $135, implying even greater upside if execution succeeds, but the report's fundamental concerns about cash burn and dilution persist.